Abnova (Taiwan) Corporation (4133.TW) TAI
21.25
+0.4(+1.92%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.25
+0.4(+1.92%)
Currency In TWD
Address
No. 108, Jhouzih Street
Taipei, 114
Taiwan (Province of China)
Phone
886 2 8751 1888
Website
Sector
Healthcare
Industry
Biotechnology
Employees
110
First IPO Date
December 28, 2009
| Name | Title | Pay | Year Born |
| Peiru Ji | GM & Director | 2.36M | N/A |
| Yaping Zhang | Accounting Supervisor | 0 | N/A |
| Yi Huang Huang | Deputy General Manager | 0 | N/A |
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.